Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29441612 | 0.79 | ALDH1A1 (0.52) | ALDH1A1HSD17B10KDM4EKMT2APOLB | |
| SCHEMBL11213802 | 0.79 | ALDH1A1 (0.52) | ALDH1A1HSD17B10KDM4EKMT2APOLB | |
| SCHEMBL2631833 | 0.76 | ALDH1A1 (0.48) | ALDH1A1HSD17B10KDM4EMAPTPOLB | |
| SCHEMBL14950486 | 0.74 | POLB (0.56) | ALDH1A1HSD17B10KDM4EMAPTKMT2A | |
| SCHEMBL28358593 | 0.74 | ALDH1A1 (0.43) | ALDH1A1HSD17B10KDM4EPOLBLMNA | |
| SCHEMBL17835532 | 0.74 | ALDH1A1 (0.43) | ALDH1A1HSD17B10KDM4EMAPTKMT2A | |
| SCHEMBL10310217 | 0.74 | POLB (0.56) | ALDH1A1HSD17B10KDM4EMAPTKMT2A | |
| SCHEMBL8577595 | 0.73 | ALDH1A1 (0.46) | ALDH1A1HSD17B10KDM4EPOLBLMNA | |
| SCHEMBL6805564 | 0.73 | ALDH1A1 (0.46) | ALDH1A1HSD17B10KDM4EPOLB | |
| SCHEMBL9910017 | 0.73 | ALDH1A1 (0.46) | ALDH1A1HSD17B10KDM4EMAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117285424-B | Preparation process of methyl acrylate by using catalyst containing active components | 山东开泰石化股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-117285424-A | Preparation process of methyl acrylate by using catalyst containing active components | 山东开泰石化股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| US-10874667-B2 | Pharmaceutical salt of antitumor heterocyclic imidazole compound | Shanghai Huilin Life Scinece & Technology Co., Ltd. (CN) | 2020-12-29 | — | — | US | disclosed |
| US-20200038394-A1 | PHARMACEUTICAL SALT OF ANTITUMOR HETEROCYCLIC IMIDAZOLE COMPOUND | SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2020-02-06 | — | — | US | disclosed |
| EP-3527566-A1 | PHARMACEUTICAL SALT OF ANTITUMOR HETEROCYCLIC IMIDAZOLE COMPOUND | Shanghai Huilun Life Science & Technology Co., Ltd (CN) | 2019-08-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874667-B2 | Pharmaceutical salt of antitumor heterocyclic imidazole compound | PARP1, PARP11, HDAC11 | ALDH1A1 117/4885HSD17B10 1840/4885KDM4E 972/4885 |
| US-20200038394-A1 | PHARMACEUTICAL SALT OF ANTITUMOR HETEROCYCLIC IMIDAZOLE COMPOUND | PARP1, PARP11, HDAC11 | ALDH1A1 117/4885HSD17B10 1840/4885KDM4E 972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.